DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Total Value
$7.13M
Total Shares
2.43M
Net Share Change
+28.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Miller Value Partners
$7.13M2.43M shares
ADD+28.6K(+1.2%)